Lead toxicity

Обзор 
Теория 
Диагноз 
Лечение 
Последующее наблюдение 
Источники 

Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice

Последний просмотренный: 20 Aug 2025

Last updated: 09 Jun 2023

Lead toxicity occurs after occupational or home exposure to lead. There is no threshold level for toxicity.

Anyone at risk of lead exposure requires screening with regular blood lead measurements. There is no "normal" level, and interventions are initiated at the first sign of increased exposure.

Lead toxicity causes neurodevelopmental dysfunction in children and a range of cardiovascular, renal, neurologic, and hematologic dysfunctions in adults.

The mainstay of treatment is removal of the source. Chelation therapy is given for blood levels ≥45 micrograms/dL in a child or >70 micrograms/dL in an adult, or if the patient is symptomatic.

Acute lead encephalopathy is a medical emergency requiring aggressive chelation therapy in an intensive care setting.

Acute symptoms resolve with treatment, but neurologic impairments and cardiovascular toxicities are irreversible.

Lead resides in bone for decades after exposure has ceased; all patients require long-term monitoring.

Определение

Lead toxicity is a multisystem disease produced by inhalation or ingestion of lead. It produces neurodevelopmental dysfunction in children and a range of cardiovascular, renal, neurologic, and hematologic dysfunctions in adults. Any detectable lead level is consistent with exposure to lead.

The US Centers for Disease Control and Prevention (CDC) employs a blood lead reference value of ≥3.5 micrograms/dL to identify children with blood lead levels greater than most other children’s levels.[1] A case definition for an elevated blood lead level in an adult (person ≥16 years of age) is ≥5 micrograms/dL.[2][3] In an adult, the US Occupational Safety and Health Administration considers a blood lead level of ≥25 micrograms/dL to be serious, requiring inspection.[2]

Анамнез и осмотр

Ключевые диагностические факторы

family history of lead poisoning or parental work with lead
cognitive impairment (children)
behavioral changes (children)
headaches (children)
clumsiness and agitation (children)
loss of appetite (children)
constipation (children)
somnolence (children)
altered mental state
cerebellar signs
seizures
coma

Полная информация

Другие диагностические факторы

colicky abdominal pain (adults)
hypertension (adults)

Полная информация

Факторы риска

age 9 to 36 months
housing with lead hazards
occupational lead exposure
lead-contaminated water supplies
low socioeconomic status
hobbies working with lead
pica
use of folk medications
fetal exposure
mineral-deficient and high-fat diets
bullet firing ranges

Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

whole-blood lead level
complete blood count
serum ferritin

Полная информация

Tests to avoid

post-chelator challenge urinary metal testing
hair or nail testing
heavy metal screening test

Полная информация

Исследования, проведение которых нужно рассмотреть

24-hour urine lead with chelation
abdominal radiographs
nerve conduction studies

Полная информация

Алгоритм лечения

Острый

all patients

Составители

Авторы

J. Routt Reigart, MD

Professor Emeritus of Pediatrics

Medical University of South Carolina

Charleston

Раскрытие информации

JRR declares that he has no competing interests.

Рецензенты

Howard Hu, MD, MPH, ScD

NSF International Chair

Department of Environmental Health Sciences

Professor of Environmental Health Sciences, Epidemiology and Internal Medicine

University of Michigan Schools of Public Health and Medicine

Ann Arbor

Раскрытие информации

HH is an author of a reference cited in this topic. HH has received research funding greater than 6 figures USD.

Rose H. Goldman, MD, MPH

Chief

Occupational & Environmental Medicine

Cambridge Health Alliance

Associate Professor of Medicine

Harvard Medical School

Associate Professor of Environmental Health Sciences

Harvard School of Public Health

Boston

Раскрытие информации

None disclosed.

Alison Jones, MD, FRCPE, FiBIOL, FRCP, FRACP

Dean

School of Medicine

Campbelltown Campus

University of Western Sydney

Australia

Раскрытие информации

AJ declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Centers for Disease Control and Prevention (CDC). Understanding blood lead levels. Adult Blood Lead Epidemiology and Surveillance (ABLES). National Institute for Occupational Safety and Health (NIOSH) workplace safety & health topics. Apr 2023 [internet publication].Полный текст

Centers for Disease Control and Prevention (CDC). Blood lead levels: United States, 1988-1991. MMWR Morb Mortal Wkly Rep. 1994;43:545-548.Полный текст Аннотация

Harvey B, ed. Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. Atlanta, GA: CDC; 2002.Полный текст

Centers for Disease Control and Prevention (CDC). Adult blood lead epidemiology and surveillance - United States, 2008-2009. MMWR Morb Mortal Wkly Rep. 2011 Jul 1;60(25):841-5.Полный текст Аннотация

Mahaffey KR. Nutrition and lead: strategies for public health. Environ Health Perspect. 1995;103(suppl 6):191S-196S.Полный текст Аннотация

Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. Household interventions for secondary prevention of domestic lead exposure in children. Cochrane Database Syst Rev. 2020 Oct 6;10:CD006047.Полный текст Аннотация

Yeoh B, Woolfenden S, Lanphear B, et al. Household interventions for preventing domestic lead exposure in children. Cochrane Database Syst Rev. 2014;(12):CD006047.Полный текст Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Отличия
- Iron deficiency anemia
- Non-lead peripheral neuropathy
- Arsenic poisoning
Больше Отличия
Рекомендации
- Childhood lead poisoning prevention
- WHO guideline for clinical management of exposure to lead
Больше Рекомендации
Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice

Использование этого контента попадает под действие нашего заявления об отказе от ответственности

Lead toxicity

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

Другие диагностические факторы

Факторы риска

Диагностические исследования

Исследования, которые показаны в первую очередь

Tests to avoid

Исследования, проведение которых нужно рассмотреть

Алгоритм лечения

all patients

Составители

Авторы

J. Routt Reigart, MD

Раскрытие информации

Рецензенты

Howard Hu, MD, MPH, ScD

Раскрытие информации

Rose H. Goldman, MD, MPH

Раскрытие информации

Alison Jones, MD, FRCPE, FiBIOL, FRCP, FRACP

Раскрытие информации

Peer reviewer acknowledgements

Disclosures

Список литературы

Основные статьи

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Отличия

Рекомендации

Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice

Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice

Войдите в учетную запись, чтобы получить полноценный доступ к BMJ Best Practice